Nanobiofab

NanoBioFab is a medical device manufacturer based in Frederick, Maryland, that develops AI-integrated nanosensor technology for real-time pathogen detection and infection management. The company’s core technology functions like a smoke detector for infections, utilizing a wearable sensor array to detect and identify trace gaseous signatures released by bacteria and fungi. By monitoring these chemical indicators alongside environmental parameters such as pressure, temperature, and humidity, the company’s AI models provide actionable insights to enable early clinical intervention. The platform is designed to be compact and easy to operate without requiring traditional laboratory settings.

This technology is aimed at transforming infection management across various medical fields, including orthopedics, wound care, urology, and pulmonology. By providing continuous, non-invasive monitoring, NanoBioFab seeks to flag infections before clinical symptoms escalate, which is particularly critical for managing surgical and chronic wounds. The company has secured multiple patents and government contracts, including support from the Defense Health Agency, and is actively engaged in clinical validation through collaborations with healthcare institutions. NanoBioFab’s dual-use platform also holds potential for military trauma care and broader biological threat detection, with initial commercial medical device releases planned for 2027.